Case report: immunotherapy successfully treated brain metastasis in intrahepatic cholangiocarcinoma and literature review

Brain metastasis from intrahepatic cholangiocarcinoma (iCCA) is extremely rare, and no standard therapeutic strategy has been established. Camrelizumab is a programmed cell death protein 1 (PD-1) inhibitor that has been widely studied in treating liver cancer. Combined immunotherapy and targeted the...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Peiyi Xie, Lei Guo, Bo Zhang, Yongfeng Xu, Qi Song, Hongcheng Shi, Qinghai Ye, Hui Li, Yongsheng Xiao
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-08-01
coleção:	Frontiers in Oncology
Assuntos:	brain metastasis advanced intrahepatic cholangiocarcinoma (iCCA) immune checkpoint inhibitors (ICIs) PD1 immunotherapy
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2022.911202/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!